Purchases and Sales Made in Q1 2024 in Agios Pharmaceuticals, Inc. (AGIO)
This table provides information about the institutional ownership of Agios Pharmaceuticals, Inc. (AGIO) during Q1 2024. The information is specifically focused on institutions that hold shares of AGIOS PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 10, 2024
Q1 2024
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-62.1K- 48.4% |
$1.32M - $2.16M
|
66.2K
$2.28M
|
|
|
May 15, 2024
Q1 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-68.4K- 11.24% |
$1.46M - $2.38M
|
540K
$18.6M
|
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-70.1K- 2.76% |
$1.49M - $2.44M
|
2.47M
$85.1M
|
|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-72.4K- 6.73% |
$1.54M - $2.52M
|
1M
$34.5M
|
|
|
May 03, 2024
Q1 2024
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-73.3K- 70.37% |
$1.56M - $2.55M
|
30.9K
$1.06M
|
|
|
May 14, 2024
Q1 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-74.3K- 63.2% |
$1.58M - $2.59M
|
43.2K
$1.49M
|
|
|
May 15, 2024
Q1 2024
|
Hudson Bay Capital Management LP
Greenwich, CT |
SELL
|
- |
-82.5K- 16.84% |
$1.76M - $2.87M
|
408K
$14M
|
|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-85.5K- 55.26% |
$1.82M - $2.98M
|
69.2K
$2.38M
|
|
|
May 15, 2024
Q1 2024
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-190K- 56.51% |
$4.05M - $6.62M
|
146K
$5.04M
|
|
|
May 10, 2024
Q1 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-304K- 6.13% |
$6.48M - $10.6M
|
4.66M
$160M
|
|
|
May 15, 2024
Q1 2024
|
Rock Springs Capital Management LP
Baltimore, MD |
SELL
|
- |
-388K- 18.01% |
$8.27M - $13.5M
|
1.76M
$60.7M
|
|
|
May 15, 2024
Q1 2024
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-560K- 15.89% |
$11.9M - $19.5M
|
2.96M
$102M
|